The Japanese government is ready to provide Ebola afflicted countries an experimental drug that has not yet been approved by the WHO
On Monday the 27th of August, Japan’s Chief Cabinet Secretary Yoshihide Suga announced that the country is willing to donate a flu drug called Favipiravir to aid the Ebola crisis in west Africa.
Mr.Suga has said that medical professionals may very well make a request for the drug, known as T-705, even though it has not yet been approved by the WHO. Mr.Suga has said that Japan will respond, under certain conditions, if requests are made for the drug.
T-705 is an anti-viral drug that works by inhibiting viral RNA-dependent RNA polymerase. It works against multiple viruses including the west nile virus, yellow fever virus, influenza viruses and others.
Despite the fact that this drug has not yet received official approval from the WHO, the WHO has said that the use of experimental Ebola drugs that have not yet been tested is ethical, considering the scale of the current Ebola outbreak.
Japan’s Fujifilm Corporation and U.S firm MediVector are in discussions with the US FDA to submit an application to expand the indications that favipravir can be used for, to include Ebola as one of them.
Read more about it here: Japan to provide experimental Ebola drug